Loading...
XLON
SUN
Market cap6mUSD
Jul 09, Last price  
0.50GBP
1D
0.00%
1Q
11.11%
Jan 2017
-88.24%
Name

Surgical Innovations Group PLC

Chart & Performance

D1W1MN
XLON:SUN chart
P/E
P/S
0.40
EPS
Div Yield, %
Shrs. gr., 5y
2.25%
Rev. gr., 5y
12.89%
Revenues
12m
-2.87%
4,460,0004,770,0004,312,0004,541,0007,045,0007,602,0007,639,0008,553,0004,029,0005,468,0006,089,0008,752,00010,969,00010,733,0006,329,0009,126,00011,340,00012,014,00011,945,00011,602,000
Net income
-895k
L-53.94%
696,000765,000630,000525,0001,788,0001,738,000686,000800,000-9,457,000-2,033,000716,000626,000725,000-2,619,000-3,276,000-456,000264,000-509,000-1,943,000-895,000
CFO
569k
P
625,000-428,0007,0001,439,0002,202,0001,775,000612,0001,268,000-485,0001,506,0002,845,0001,608,0001,650,000594,0001,042,000-433,000486,000400,000-74,000569,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1988 and headquartered in Leeds, United Kingdom, Surgical Innovations Group plc is an international enterprise engaged in the design, development, manufacturing, and marketing of devices for minimally invasive surgery (SI) and precision engineering applications. Its global presence extends across the UK, Europe, the Asia Pacific region, and the United States. The company operates through three distinct divisions: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The SI Brand segment is responsible for the research, development, production, and commercialization of its proprietary SI-branded minimally invasive instruments. Key products within this portfolio include the YelloPort Elite and YelloPort +plus laparoscopic port access systems, LogiRange resposable laparoscopic instrument systems, FastClamp laparoscopic clamping systems, and QuickRange single-use laparoscopic instrumentation. The OEM division focuses on crafting and supplying minimally invasive devices for third-party medical device firms, often under their own brand or through co-branding arrangements. This segment also provides comprehensive design and development solutions for creating final medical devices and is involved in the research, development, manufacturing, and sale of minimally invasive technology tailored for precision engineering. Lastly, the Distribution segment handles the supply of various medical products, primarily via its subsidiary, Elemental Healthcare Ltd, and also designs and produces autologous blood products. Surgical Innovations Group plc sells its offerings through a network of independent healthcare distributors, while its own-label products are also distributed through its OEM collaborations.
IPO date
Jul 07, 1998
Employees
92
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT